 |
|
Dual treatment of incontinence and dementia associated with functional decline
May 01, 2008WINSTON-SALEM, N.C. - Older nursing home residents who took medications for dementia and incontinence at the same time had a 50 percent faster decline in function than those who were being treated only for dementia, according to a study from researchers at Wake Forest University School of Medicine and colleagues.
"It is likely that the oppositional effects of the drugs contributed to the accelerated decline," said Kaycee M. Sink, M.D., M.A.S., lead author. "Over a year's time, the decline we observed would represent a resident going from requiring only limited assistance in an activity to being completely dependent, or from requiring only supervision to requiring extensive assistance in an activity."
The combination of drugs affected older adults who started out with higher levels of function in activities of daily living such as dressing, personal hygiene, toileting, transferring, bed mobility, eating and being able to get around the unit. The results were published online by the Journal of the American Geriatrics Society and will appear in a future print issue.
The two most common medical conditions among nursing home residents are dementia and urinary incontinence and they often coexist. The study involved 395 nursing home residents in Indiana who were taking medications for both conditions and 3,141 who were taking only a dementia medication.
Residents included in the analysis were age 65 and older and had had at least two consecutive prescriptions for cholinesterase inhibitors, a family of drugs used to treat dementia. Examples include donepezil (Aricept®), galantamine (Razadyne®), rivastigmine (Exelon®), and tacrine (Cognex®). These drugs are designed to increase levels of acetylcholine, a chemical that enhances communication between nerve cells in the brain.
About 10 percent of the residents were also taking either oxybutynin or tolterodine, the two most commonly prescribed drugs for urinary incontinence. These drugs are known as anticholinergic agents and are designed to block acetylcholine.
"The two drugs are pharmacological opposites, which led us to hypothesize that the simultaneous treatment of dementia and incontinence could lead to reduced effectiveness of one or both drugs," said Sink, an assistant professor of internal medicine-gerontology.
She said the finding of the more rapid decline among residents taking both types of drugs represents a significant public health problem because an estimated 33 percent of people with dementia also take a drug for incontinence.
"Until now, the clinical dilemma for managing incontinence and dementia has been largely theoretical. This research suggests it may lead to worse outcomes, which is the opposite intention of therapy for dementia."
The researchers also measured whether the residents taking both drugs also experienced a decline in mental function, but there was no difference between the two groups, possibly because the test was not sensitive enough. Sink said that similar research should be extended to community-dwelling older adults with dementia and that more sensitive measures for cognition should be used. Previous studies have shown that the bladder medications are associated with cognitive decline and that people with dementia are especially sensitive to this side effect.
"The results suggest that clinicians should continue to try non-drug management strategies for incontinence before beginning therapy with one of these common drugs," said Sink.
She noted that the study was conducted in 2003 and 2004, before newer incontinence medications were introduced that may have less effect on acetylcholine in the brain.
Wake Forest University Baptist Medical Center
The two most common medical conditions among nursing home residents are dementia and urinary incontinence and they often coexist. The study involved 395 nursing home residents in Indiana who were taking medications for both conditions and 3,141 who were taking only a dementia medication.
Residents included in the analysis were age 65 and older and had had at least two consecutive prescriptions for cholinesterase inhibitors, a family of drugs used to treat dementia. Examples include donepezil (Aricept®), galantamine (Razadyne®), rivastigmine (Exelon®), and tacrine (Cognex®). These drugs are designed to increase levels of acetylcholine, a chemical that enhances communication between nerve cells in the brain.
About 10 percent of the residents were also taking either oxybutynin or tolterodine, the two most commonly prescribed drugs for urinary incontinence. These drugs are known as anticholinergic agents and are designed to block acetylcholine.
"The two drugs are pharmacological opposites, which led us to hypothesize that the simultaneous treatment of dementia and incontinence could lead to reduced effectiveness of one or both drugs," said Sink, an assistant professor of internal medicine-gerontology.
She said the finding of the more rapid decline among residents taking both types of drugs represents a significant public health problem because an estimated 33 percent of people with dementia also take a drug for incontinence.
"Until now, the clinical dilemma for managing incontinence and dementia has been largely theoretical. This research suggests it may lead to worse outcomes, which is the opposite intention of therapy for dementia."
The researchers also measured whether the residents taking both drugs also experienced a decline in mental function, but there was no difference between the two groups, possibly because the test was not sensitive enough. Sink said that similar research should be extended to community-dwelling older adults with dementia and that more sensitive measures for cognition should be used. Previous studies have shown that the bladder medications are associated with cognitive decline and that people with dementia are especially sensitive to this side effect.
"The results suggest that clinicians should continue to try non-drug management strategies for incontinence before beginning therapy with one of these common drugs," said Sink.
She noted that the study was conducted in 2003 and 2004, before newer incontinence medications were introduced that may have less effect on acetylcholine in the brain.
Wake Forest University Baptist Medical Center
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
HIV transmission Reflux Disease Post-traumatic Stress Birth Weight Nanoparticles Earthquakes Mars Water Dendritic Cells Atmospheric Carbon Dioxide Pain Polio Estrogen Receptor Gecko Video Games Heart Disease Child Care Tobacco Erectile dysfunction Tooth Loss Genomics Titan OCD Attractiveness Opioid
See More: Science News Tags
Incontinence Current Events and Incontinence News RSSSome neural tube defects in mice linked to enzyme deficiency
Women of childbearing age can reduce the risk of having a child born with a neural tube defect such as spina bifida by eating enough folate or folic acid. However, folate prevents only about 70 percent of these defects.
Uterus sparing surgery is a safe and effective treatment for pelvic organ prolapse
Researchers presented data at the 104th Annual Scientific Meeting of the American Urological Association (AUA) showing that uterus sparing surgery is an effective and safe treatment for women who want to preserve the integrity of vaginal function after pelvic organ prolapse.
Autologous muscle-derived cells may treat stress urinary incontinence
Researchers have confirmed that transplanting autologous muscle-derived cells (AMDC) into the bladder is safe at a wide range of doses and significantly improves symptoms and quality of life in patients with stress urinary incontinence.
M. D. Anderson study finds pre-surgical stress management improves mood, quality of life
Brief stress management sessions prior to and immediately after surgery may have both short- and long-term benefit for men undergoing a radical prostatectomy for early-stage prostate cancer.
U.S. trial shows no early mortality benefit from annual prostate cancer screening
The prostate cancer screening tests that have become an annual ritual for many men don't appear to reduce deaths from the disease among those with a limited life-expectancy, according to early results of a major U.S. study involving 75,000 men.
Collagen injections can help some incontinence patients when surgery fails, researcher finds
Collagen injections can benefit women who still suffer from stress urinary incontinence (SUI) even after urethral or periurethral surgery, a UT Southwestern Medical Center researcher has found.
Selected men with low-risk prostate cancer have good clinical outcomes without immediate treatment
A multi-center study of prostate cancer patients appearing in today's Journal of Urology recommends that for some men diagnosed with low-risk prostate cancer, opting not to initially receive treatment can be safe if they are closely monitored.
Freezing prostate cancer does a man's body good
The so-called "male lumpectomy"-a minimally invasive interventional radiology treatment for prostate cancer-is as effective as surgery in destroying diseased tumors and can be considered a first-line treatment for patients of all risk levels and particularly those who have failed radiation, according to studies released at the Society of Interventional Radiology's 34th Annual Scientific Meeting.
Weight Loss Reduces Incontinence for Women
Starting a weight-loss regimen significantly reduces urinary incontinence for women, according to researchers at the University of Alabama at Birmingham (UAB) and the University of California, San Francisco.
New study shows that a cough medicine ingredient could effectively treat prostate cancer
A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer.
More Incontinence Current Events and Incontinence News Articles
 |
Urinary & Fecal Incontinence: Current Management Concepts by Dorothy B. Doughty MN RN CWOCN FAAN (Author) Completely updated to reflect current practice, the 3rd edition of this comprehensive resource provides a multi-disciplinary, in-depth review of the physiology of continence, the pathologic mechanisms producing incontinence, and current treatment options for the various types of incontinence. Assessment, behavioral therapies, and multidisciplinary care are emphasized as key elements in the treatment and management of incontinence. In addition to the life-span content discussed throughout the book, an entire chapter is devoted to bowel and bladder management in children. Authored and contributed by leaders in the Wound, Ostomy and Continence Nurses Society (WOCN). Provides an in-depth review of the physiology of continence, the pathologic mechanisms producing incontinence, and... |
 |
Depend Boost Inserts, Case of Six-20 Count (120 Inserts) by Depend Only for use with your disposable absorbent undergarment. Added protection against leaks. Designed exclusively for use in disposable briefs, undergarments and protective underwear! Depend Boost Inserts have a specially designed layer to work with your regular absorbent garment to help protect against leaks and odors. Odor Absorbing Core contains highly absorbent material that locks in liquids to reduce and neutralize odor. Individually Wrapped: Discreet package to take with you anywhere. Size: Fits in any disposable absorbent product. Gender: Male and female. Made in U.S.A. |
 |
Incontinence Solution by Fireside Books Millions of women experience difficulties controlling their bladders but suffer in silence, reluctant to speak to their doctors -- or even to their best friends -- about the problem. Here, at last, women will find the most up-to-date medical explanations and state-of-the-art solutions, including: Controversial links between current childbirthing practices -- like episiotomy, the use of forceps, and long labor -- and the development of incontinence later in life. Advanced diagnostic tests that enable women to quickly find the most effective treatment. Nonsurgical treatments: pelvic muscle exercises and oral medications that really work. Surgical options featuring new minimally invasive outpatient procedures. |
 |
Managing and Treating Urinary Incontinence, Second Edition by Diane Kaschak Newman (Author), Alan J. Wein (Author) Incontinence is not an inevitable part of aging, nor is it untreatable once it develops. Thoroughly revised and updated, this new edition of a trusted resource teaches diverse and effective strategies for assessing, managing, and even eliminating urinary incontinence in all care settings.
|
 |
Priva Ultra Plus Waterproof Sheet Protector, 34" x 52", White by Priva Keeps sheets dry all night. Unique brushed polyester fabric channels fluid away from the surface for maximum comfort and ultra-dry surface. Absorbs quickly and locks in moisture for the best in skin care. Goes over the bottom sheet to protect mattress AND sheets from moisture and staining. No more middle-of-the-night bed stripping, simply replace the Priva sheet protector with a fresh one in seconds! Non-slip backing. Waterproof. 34" x 52" |
 |
Overcoming Urinary Incontinence: A Woman's Guide to Treatment by Michael H. Safir MD (Author), Clay N. Boyd MD (Author), Tony E. Pinson MD (Author) Addressing the most commonly asked questions about incontinence, this accessible reference discusses causes, types of incontinence, and how the condition is diagnosed. The wide range of treatment options is introduced, from pelvic floor therapy and bladder training to electrical stimulation, medications, and surgeries. Eleven million women in the U.S. are coping with urinary incontinence—half of whom are too embarrassed to discuss the matter with their doctors—and this guidebook provides encouragement, showing that in more than 80 percent of cases, treatment can improve or even cure the problem.
|
 |
Tranquility ATN (All-through-the-Night) Fitted Briefs Size Medium Pk/12 by Principle Business Enterprises Tranquility ATNs have maximum capacity in a disposable brief. Users can sleep all through the night uninterrupted by garment changes without compromising skin safety. A patented Peach Mat Construction with superabsorbent polymers guarantees skin dryness, odor control, neutralization of urine and inhibition of bacterial growth. Reducing wet linens and extra laundry, ATNs provide a greater peace of mind for the caregiver and the user. Latex-free. |
 |
Therapeutic Management of Incontinence and Pelvic Pain: Pelvic Organ Disorders by Springer Chapters in this 2nd revised edition cover the management and treatment of bladder and bowel dysfunctions in men and women, pelvic organ prolapse; issues concerning the elderly, neurologically impaired patients and those with pelvic pain. Allied updated chapters are on research methodology, the importance of fluids and infection control. New chapters cover quality of life, treatment of bladder and bowel dysfunction in children, the history of pelvic floor muscle exercise and manual therapy. The use of real-time ultrasound to evaluate pelvic floor muscle contractility, exercise balls to promote coordination of trunk stabilisers and the pelvic floor muscles, and the role of the Occupational Therapist are discussed, completed with a new section on ethical issues in the management of... |
 |
Beyond Kegels: Fabulous Four Exercises & More to Prevent & Treat Incontinence 2nd Ed. by Janet A. Hulme (Author) Incontinence is not a normal part of aging and can be prevented. This book details the Beyond Kegels program, an innovative, conservative approach to preventing and treating incontinence. Simple exercises that anyone of any age can do, take only minutes per day. When combined with simple lifestyle modifications, this program is effective for the prevention and treatment of overactive bladder, urge, stress and mixed incontinence without the side effects of medication. |
 |
Blue Disposable Underpads (Chux), Large Size 23 x 36, Case/100 (4 bags of 25) by Principle Business Enterprises These Blue Underpads (Chux) are the best value available for a high-quality blue pad. They are latex-free with a diamond embossed quilt pattern. Protects bedding, furniture, or wheelchairs from leakage. Designed with a highly absorbent embossed core and soft, quick-drying coverstock. (4 bags of 25) |
| © 2009 BrightSurf.com |